Home・Lista de Ações・Revvity Inc

Revvity Inc

Abrir

SetorSaúde

115.91 0.95

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

112.61

Máximo

116.34

Indicadores-chave
By Trading Economics
Rendimento	-58M 41M
Vendas	-61M 711M
P/E Médio do Setor	55.394 68.51
EPS	1.06
Rendimento de Dividendos	0.25
Margem de lucro	5.726
Funcionários	11,000
EBITDA	-38M 180M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+0.42% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	0.25% 2.29%
Próximos Ganhos	26 de out. de 2026
Próxima data de ex-dividendo	23 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	3.2B 13B
Abertura anterior	114.96
Fecho anterior	115.91

Sentimento de Notícias

By Acuity

29%

71%

48 / 340 Ranking em Healthcare

Revvity Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de ago. de 2026, 19:46 UTC

Revvity Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

6 de ago. de 2026, 20:51 UTC

Revvity Inc shares are lower in after-market hours, with no specific news identified. The asset remains above its 20-day moving average.

5 de ago. de 2026, 19:52 UTC

News

Revvity Inc shares are higher as Evercore ISI raises its price target to $126, supported by strong quarterly performance and increased guidance.

4 de ago. de 2026, 19:51 UTC

Social Media

News

Revvity Inc shares are lower following second-quarter results that showed organic revenue growth of 3% and a slight miss on overall revenue estimates.

3 de ago. de 2026, 19:44 UTC

News

Revvity Inc shares are higher ahead of tomorrow's earnings report, with analysts projecting a 3.9% revenue growth year-on-year, recovering from last year's decline.

31 de jul. de 2026, 19:16 UTC

Revvity Inc shares are lower today amid broader market declines, influenced by rising yields and inflation concerns following a significant increase in crude oil prices.

29 de jul. de 2026, 20:08 UTC

Revvity Inc shares are higher today, reflecting a steady upward trend amid rising oil prices and broader market influences. The stock is near its one-month range high.

28 de jul. de 2026, 20:03 UTC

Revvity Inc shares are higher during Tuesday's session, continuing their advance since Monday's close, despite broader market weakness in Asian indices.

27 de jul. de 2026, 21:02 UTC

Revvity Inc shares are lower in after-market hours, continuing a downward trend with three consecutive daily declines. No specific news was identified for the movement.

22 de jul. de 2026, 18:51 UTC

Revvity Inc shares are higher since Tuesday's close amid broader market gains, influenced by rising crude oil prices from geopolitical tensions involving the U.S. and Iran.

21 de jul. de 2026, 20:02 UTC

Revvity Inc shares are higher, supported by renewed interest in AI stocks and anticipation of earnings from major companies like Alphabet and Tesla.

20 de jul. de 2026, 19:21 UTC

News

Revvity Inc. published its 2026 Impact Report, disclosing Scope 3 emissions. Shares are lower amid broader industry challenges and a cautious analyst outlook.

Comparação entre Pares

Variação de preço

Revvity Inc Previsão

Preço-alvo

By TipRanks

0.42% parte superior

Previsão para 12 meses

Média 115.14 USD 0.42%

Máximo 130 USD

Mínimo 105 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para Revvity Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

11 ratings

Comprar

Manter

Vender

Com base em 11 analistas que deram avaliações de ações para Revvity Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

48 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.